Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 14 EU countries
White Paper: Evidence requirements for medical devices in the regional HTA program in Italy
Get insights from MTRC White Papers to advance your understanding of five rapid HTA reports from the Tuscany region
Recent news and posts
Rapid HTAs of two medical devices released in Tuscany in August 2026
Tuscany remains the most active Italian region in conducting HTA for medical devices, with HTA-based recommendations influencing regional adoption and procurement decisions.
Under Regional Decree No.17185 of July 29, 2026, the Tuscany Regional Healthcare Authority released two new rapid HTA reports. Both devices received a favorable opinion on the purchase:
- ProACT adjustable prosthesis for the treatment of male urinary incontinence (by Uromedica);
- H1 HIP Resurfacing cementless ceramic-on-ceramic hip joint prosthesis (by Embody), intended for use in young patients with early-stage hip osteoarthritis who have an active or athletic lifestyle, high functional demands, and adequate bone quality and density.
This news is just one of about 300 market access news and updates collected by our team in the premium subscription service MTRC Access Intelligence every week from more than 80 organizations. Access our paid service to stay on top of all developments, specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, six-week, no-obligation trial.